- Permira has acquired a majority stake in behavioral biometrics company BioCatch.
- Existing shareholders, Sapphire Ventures and Macquarie Capital, have also increased their stake in BioCatch.
- The moves have boosted BioCatch’s valuation to $1.3 billion, which is up from $1 billion last year.
Behavioral biometrics company BioCatch announced it has a new majority shareholder. Permira Growth Opportunities II, a fund advised by U.K.-based global private equity firm Permira, has acquired a majority stake in the Israel-based company by buying out shares from Bain Capital Tech Opportunities and Maverick Ventures in a secondary transaction.
Two of the company’s existing shareholders, Sapphire Ventures and Macquarie Capital, have also increased their stake in BioCatch. While specific terms of the transactions were not disclosed, the company’s valuation is now estimated at $1.3 billion.
BioCatch expects the move will help it accelerate its product roadmap and support its growth in general. The increased commitment from Permia will also aid BioCatch’s global expansion efforts. Specifically, the fraud prevention company will leverage Permia’s Continental European ties, with an aim to add new clients in that region.
“After building a strong partnership with Permira over the last year, we are delighted to welcome them as majority shareholders,” said BioCatch CEO Gadi Mazor. “The firm’s impressive experience within technology and cybersecurity, combined with their scale, global network, and our close working relationship, has been invaluable since their initial investment.”
BioCatch was founded in 2011 and has since raised around $324 million in disclosed funding. The company leverages behavioral biometric intelligence to offer account opening fraud detection, mule account detection, account takeover protection, customer authentication solutions, and more. BioCatch currently has more than 190 financial institution customers across the globe, including over 30 of the world’s largest 100 global banks.
Today’s announcement comes a year after BioCatch earned $1 billion following a $40 million investment from Permia. The move made Permia a significant minority shareholder in BioCatch, right behind Sapphire Ventures and Macquarie Capital.
“We have tracked BioCatch with enthusiasm for many years, and now having been a shareholder since early 2023, our conviction in the business, its growth potential, its technology leadership, and its management team continues to grow,” said Permia Growth Opportunities Partner and Co-Head Stefan Dziaski. “We’re excited to become the company’s majority shareholder and look forward to a continued successful partnership with Gadi and the BioCatch team as we seek to further accelerate growth and expansion in the years to come.”
Photo by George Prentzas on Unsplash